6β-Μethyl Prednisolone 21-Acetate

• CAT Number: R057186
• CAS Number: 1048031-82-8
• Molecular Formula: C24H32O6
• Molecular Weight: 416.514
• Purity: ≥95%
• Synonyms: (6β,11β)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione
• Storage: Store at +4 ℃
• IUPAC Name: [2-[(6R,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
• InChI: InChI=1S/C24H32O6/c1-13-9-16-17-6-8-24(29,20(28)12-30-14(2)25)23(17,4)11-19(27)21(16)22(3)7-5-15(26)10-18(13)22/h5,7,10,13,16-17,19,21,27,29H,6,8-9,11-12H2,1-4H3/t13-,16+,17+,19+,21-,22+,23+,24+/m1/s1
• InChIKey: PLBHSZGDDKCEHR-GUTMJZMYSA-N
• SMILES: CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O

6β-Methyl Prednisolone 21-Acetate is a synthetic corticosteroid derived from prednisolone, designed to enhance anti-inflammatory and immunosuppressive properties. The introduction of a methyl group at the 6β position and an acetate group at the 21 position modifies its pharmacodynamic and pharmacokinetic profiles, potentially improving its potency and duration of action. This compound is used in various clinical settings to manage and treat inflammatory conditions, autoimmune disorders, and allergic reactions, offering a targeted approach to corticosteroid therapy.